おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MagnaMedics
company
About
MagnaMedics has established itself as a valued partner for routine.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Biotechnology,Nanotechnology,Project Management
- Founded date
- Jan 1, 2003
- Number Of Employee
- 1 - 10
- Operating Status
- Active
MagnaMedics engineers and produces magnetic nano- and microparticles that are used in medical devices, drug delivery tools and diagnostic kits. Diagnostic kits are used for determination of biomarkers in body fluids; the company focuses on proteomics and more specifically on high-quantity isolation of proteins as well as on research customers active in high-throughput screening of biomarkers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
MagnaMedics has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Feb 1, 2011 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 1, 2011 | Series B | — | 2 | — | — | Detail |
| Jan 1, 2008 | Series Unknown | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
MagnaMedics is funded by 2 investors.
BioScience Ventures Group
and Limburg Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
BioScience Ventures Group
|
— | Series B |
Limburg Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
